{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:06:31Z","timestamp":1783019191081,"version":"3.54.6"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.xphs.2024.08.021","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T03:55:08Z","timestamp":1724471708000},"page":"3279-3285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Developing analytical ion exchange chromatography methods for antibody drug conjugates containing the hydrolysis-prone succinimide-thioether conjugation chemistry"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9541-2895","authenticated-orcid":false,"given":"Jessica","family":"Webb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chendi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-8330","authenticated-orcid":false,"given":"Methal","family":"Albarghouthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.xphs.2024.08.021_bib0001","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/jps.21180","article-title":"Heterogeneity of monoclonal antibodies","volume":"97","author":"Liu","year":"2008","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2024.08.021_bib0002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/antib8010018","article-title":"Macro- and micro-heterogeneity of natural and recombinant IgG antibodies","volume":"8","author":"Beck","year":"2019","journal-title":"Antibodies"},{"issue":"5","key":"10.1016\/j.xphs.2024.08.021_bib0003","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4161\/mabs.21328","article-title":"Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies","volume":"4","author":"Du","year":"2012","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.xphs.2024.08.021_bib0004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4161\/mabs.2.6.13333","article-title":"Charge variants in IgG1","volume":"2","author":"Khawli","year":"2010","journal-title":"MAbs"},{"issue":"1","key":"10.1016\/j.xphs.2024.08.021_bib0005","doi-asserted-by":"crossref","first-page":"2259289","DOI":"10.1080\/19420862.2023.2259289","article-title":"Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity","volume":"15","author":"Lietz","year":"2023","journal-title":"MAbs"},{"issue":"4","key":"10.1016\/j.xphs.2024.08.021_bib0006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12257-023-0078-4","article-title":"Bioprocess challenges in purification of therapeutic protein charge variants","volume":"28","author":"Gupta","year":"2023","journal-title":"Biotechnol Bioprocess Eng"},{"issue":"23","key":"10.1016\/j.xphs.2024.08.021_bib0007","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1021\/ac402384y","article-title":"Arginine modifications by methylglyoxal: discovery in a recombinant monoclonal antibody and contribution to acidic species","volume":"85","author":"Chumsae","year":"2013","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.xphs.2024.08.021_bib0008","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody\u2013drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2024.08.021_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","article-title":"Antibody\u2013drug conjugates: a comprehensive review","volume":"18","author":"Khongorzul","year":"2020","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.xphs.2024.08.021_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"10.1016\/j.xphs.2024.08.021_bib0011","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.3390\/molecules26195847","article-title":"An insight into FDA approved antibody-drug conjugates for cancer therapy","volume":"26","author":"Tong","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.xphs.2024.08.021_bib0012","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1039\/D0CS00310G","article-title":"Site-selective modification strategies in antibody\u2013drug conjugates","volume":"50","author":"Walsh","year":"2021","journal-title":"Chem Soc Rev"},{"issue":"2","key":"10.1016\/j.xphs.2024.08.021_bib0013","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/bc5004982","article-title":"Site-specific antibody\u2013drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development","volume":"26","author":"Agarwal","year":"2015","journal-title":"Bioconjug Chem"},{"issue":"6","key":"10.1016\/j.xphs.2024.08.021_bib0014","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/19420862.2019.1628589","article-title":"Impact of linker-drug on ion exchange chromatography separation of antibody-drug conjugates","volume":"11","author":"Zhang","year":"2019","journal-title":"MAbs"},{"key":"10.1016\/j.xphs.2024.08.021_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.123174","article-title":"Development of a sub-hour on-line comprehensive cation exchange chromatography x RPLC method hyphenated to HRMS for the characterization of lysine-linked antibody-drug conjugates","volume":"240","author":"Chapel","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.xphs.2024.08.021_bib0016","doi-asserted-by":"crossref","first-page":"462761","DOI":"10.1016\/j.chroma.2021.462761","article-title":"Eliminating protein oxidation artifacts during high performance liquid chromatography peak fractionation processes","volume":"1663","author":"Niu","year":"2022","journal-title":"J Chromatogr A"},{"issue":"1","key":"10.1016\/j.xphs.2024.08.021_bib0017","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc5005262","article-title":"Long-term stabilization of maleimide\u2013thiol conjugates","volume":"26","author":"Fontaine","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2024.08.021_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ddtec.2018.07.002","article-title":"Minireview: addressing the retro-Michael instability of maleimide bioconjugates","volume":"30","author":"Szijj","year":"2018","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.xphs.2024.08.021_bib0019","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jconrel.2015.09.032","article-title":"Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides","volume":"220","author":"Christie","year":"2015","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.xphs.2024.08.021_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/antib6040020","article-title":"Pyrrolobenzodiazepine antibody-drug conjugates designed for stable thiol conjugation","volume":"6","author":"Christie","year":"2017","journal-title":"Antibodies"},{"key":"10.1016\/j.xphs.2024.08.021_bib0021","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jpba.2018.11.009","article-title":"Multi-arm PEG-maleimide conjugation intermediate characterization and hydrolysis study by a selective HPLC method","volume":"164","author":"Wang","year":"2019","journal-title":"J Pharm Biomed Anal"},{"issue":"22","key":"10.1016\/j.xphs.2024.08.021_bib0022","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1016\/j.bmcl.2007.09.002","article-title":"Catalysis of imido group hydrolysis in a maleimide conjugate","volume":"17","author":"Kalia","year":"2007","journal-title":"Bioorganic Med Chem Lett"},{"issue":"4","key":"10.1016\/j.xphs.2024.08.021_bib0023","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4161\/mabs.28762","article-title":"A new tool for monoclonal antibody analysis","volume":"6","author":"An","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.xphs.2024.08.021_bib0024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ab.2016.12.017","article-title":"Characterization of charge variants of a monoclonal antibody using weak anion exchange chromatography at subunit levels","volume":"520","author":"Ponniah","year":"2017","journal-title":"Anal Biochem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924003423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924003423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T07:31:57Z","timestamp":1730964717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924003423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0022354924003423"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.08.021","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing analytical ion exchange chromatography methods for antibody drug conjugates containing the hydrolysis-prone succinimide-thioether conjugation chemistry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}